Austco Healthcare (AHC) H1 2025 earnings summary

Executive summary

• Achieved record half-year revenue of $36.9 million, up 62% year-over-year, driven by acquisitions and strong organic growth in Asia and North America.

• EBITDA rose 150% to $5.2 million, exceeding guidance, with operating leverage from higher revenues.

• Net profit after tax increased 150.1% to $2.9 million, while net profit before tax surged 270% to $3.9 million, reflecting improved profitability.

• No interim dividend declared to support growth and acquisition earnout payments.

Financial highlights

• Revenue from activities grew to $36.9 million from $22.8 million year-over-year.

• Gross margin dollars rose to $18.8 million, though gross margin percentage declined to 51.1% from 51.9% due to lower-margin acquisitions.

• EBITDA reached $5.2 million, up from $2.1 million; EBIT was $3.8 million, up from $1.1 million.

• Cash position at period end was $14.9 million (including $5.7 million in term deposits), with the company remaining debt free.

• Software and SMA revenues grew 15% to $4.6 million, now 12.5% of group revenue.

Outlook and guidance

• Unfilled Contracted Revenue (UCR) remains strong at $50.2 million as of February 2025, supporting future revenue visibility.

• Software and SMA revenues expected to play a growing role, comprising 19.4% of UCR.

• Focus areas include innovation, product development, strategic M&A, and partnerships to drive sustainable growth.

• Commitment to operational efficiency, cost management, and maximizing revenue streams to support long-term value creation.